Experimental respiratory syncytial virus infection of four species of primates
β Scribed by Dr. Robert B. Belshe; Linda S. Richardson; William T. London; D. Lewis Sly; John H. Lorfeld; Ena Camargo; David A. Prevar; Robert M. Chanock
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 322 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Four species of nonhuman primates were inoculated intranasally with 10^3.1^ to 10^3.7^ plaque forming units (pfu) of respiratory syncytial (RS) virus. Adult squirrel monkeys and newborn rhesus monkeys became infected and shed small quantities (peak titer 10^2.0^ pfu/ml of nasopharyngeal swab specimen) of virus, but illness did not develop. Infant cebus monkeys aged 2 months became infected, shed 10^2.3^ to 10^3.8^ pfu/ml of nasopharyngeal swab specimen, but did not become ill. Chimpanzees aged 15 to 18 months shed a large quantity of virus, up to 10^6.0^ pfu/ml of nasopharyngeal swab specimen and developed an upper respiratory illness. Chimpanzees are proposed as a possible animal model for future study of the immunopathology of RS virus desease and for in vivo evaluation of attendated live virus vaccine candidates.
π SIMILAR VOLUMES
## Abstract __Pseudomonas aeruginosa__ causes opportunistic infections in immunocompromised individuals and patients ventilated mechanically and is the major pathogen in patients with cystic fibrosis, in which it causes chronic infections. Epidemiological, in vitro and animal data suggest a role fo
During the course of 26 respiratory syncytial (RS) virus infections, infected cells in the respiratory tract become coated with immunoglobulins (IgA, IgG, and IgM), IgA being predominant. Methods are described for detecting both intracellular virus and coating immunoglobulin using a double staining
An assay for respiratory syncytial virus (RSV)specific IgG in saliva is described. The assay was used to examine the incidence of RSV infection in schoolchildren 7-10 years old during one RSV season. One hundred and twenty-one volunteer children provided saliva samples in October 1997 and March 1998
## Abstract Respiratory syncytial virus (RSV) is a major cause of respiratory tract disease in infants, aged adults, and immunosuppressed patients. The only approved medicines for RSV disease are administration of prophylatic antibodies or treatment with a synthetic nucleoside. Both approaches are
## Abstract Virus respiratory infections often precede bacterial pneumonia in healthy individuals. In order to determine the potential role of respiratory syncytial virus (RSV) in bacterial secondary infections, a mouse sequential pulmonary infection model was developed. Mice were exposed to RSV th